These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


215 related items for PubMed ID: 12944340

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Moclobemide versus clomipramine in depressed patients in general practice. A randomized, double-blind, parallel, multicenter study.
    Kragh-Sørensen P, Müller B, Andersen JV, Buch D, Stage KB.
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):24S-30S. PubMed ID: 7593726
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
    Leinonen E, Lepola U, Koponen H, Mehtonen OP, Rimon R.
    Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial.
    Braconnier A, Le Coent R, Cohen D, DEROXADO Study Group.
    J Am Acad Child Adolesc Psychiatry; 2003 Jan; 42(1):22-9. PubMed ID: 12500073
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
    Funke HJ, Moritz E, Hellstern K, Malanowski H.
    Acta Psychiatr Scand Suppl; 1990 Jan; 360():46-7. PubMed ID: 2248069
    [Abstract] [Full Text] [Related]

  • 10. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
    Dierick M, Cattiez P, Franck G, Burton P, Defleur J, Hermans W, Roelandts A, Wolfrum C, Berger M, Hellstern K.
    Acta Psychiatr Scand Suppl; 1990 Jan; 360():50-1. PubMed ID: 2248071
    [Abstract] [Full Text] [Related]

  • 11. The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine.
    Bech P, Stage KB, Larsen JK, Vestergaard P, Gram LF, DUAG.
    J Affect Disord; 2012 Nov; 140(3):253-9. PubMed ID: 22381949
    [Abstract] [Full Text] [Related]

  • 12. Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings.
    Gómez Gómez JM, Teixidó Perramón C.
    J Clin Psychiatry; 2000 Apr; 61(4):285-9. PubMed ID: 10830150
    [Abstract] [Full Text] [Related]

  • 13. [Use of antidepressant drugs in schizophrenic patients with depression].
    Micallef J, Fakra E, Blin O.
    Encephale; 2006 Apr; 32(2 Pt 1):263-9. PubMed ID: 16910628
    [Abstract] [Full Text] [Related]

  • 14. Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.
    Dingemanse J, Kneer J, Fotteler B, Groen H, Peeters PA, Jonkman JH.
    J Clin Psychopharmacol; 1995 Feb; 15(1):41-8. PubMed ID: 7714227
    [Abstract] [Full Text] [Related]

  • 15. Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study.
    Ottevanger EA.
    Encephale; 1995 Feb; 21(4):317-21. PubMed ID: 7588171
    [Abstract] [Full Text] [Related]

  • 16. Dimensional assessment of onset of action of antidepressants: a comparative study of moclobemide vs. clomipramine in depressed patients with blunted affect and psychomotor retardation.
    Jouvent R, Le Houezec J, Payan C, Mikkelsen H, Fermanian J, Millet V, Dufour H.
    Psychiatry Res; 1998 Jul 13; 79(3):267-75. PubMed ID: 9704873
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of antidepressants: why and how they are relevant to treatment.
    Preskorn SH.
    J Clin Psychiatry; 1993 Sep 13; 54 Suppl():14-34; discussion 55-6. PubMed ID: 8407856
    [Abstract] [Full Text] [Related]

  • 18. Gender differences in treatment response to sertraline versus imipramine in chronic depression.
    Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Davis SM, Harrison WM, Keller MB.
    Am J Psychiatry; 2000 Sep 13; 157(9):1445-52. PubMed ID: 10964861
    [Abstract] [Full Text] [Related]

  • 19. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
    Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM.
    J Clin Psychiatry; 2000 Apr 13; 61(4):276-81. PubMed ID: 10830148
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of the efficacy of traditional antidepressive agents and the new generation of antidepressives in the treatment of depressive disorders].
    Cvjetković-Bosnjak M, Knezević A, Soldatović-Stajić B.
    Med Pregl; 1999 Apr 13; 52(3-5):108-11. PubMed ID: 10518394
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.